1. Repositório Institucional - INCA
  2. Comunicação
  3. Revistas e Informes
  4. Informe INCA
  5. Informe INCA 2023
  6. Informe INCA 427
Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/13150
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2023-03-17T16:15:32Z-
dc.date.available2023-03-17T16:15:32Z-
dc.date.issued2023-01-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/13150-
dc.language.isoporpt_BR
dc.publisherINCApt_BR
dc.subjectNeoplasias Peritoneaispt_BR
dc.subjectPeritoneal Neoplasmspt_BR
dc.subjectNeoplasias Peritonealespt_BR
dc.subjectSobrevidapt_BR
dc.subjectSurvivalpt_BR
dc.subjectQuimioterapia Intraperitoneal Hipertérmicapt_BR
dc.subjectHyperthermic Intraperitoneal Chemotherapypt_BR
dc.subjectPaclitaxelpt_BR
dc.titleINCA é pioneiro em alternativa de tratamento para câncer de estômago com doença peritoneal avançadapt_BR
dc.title.alternativeInforme INCA 427pt_BR
dc.TypePeriodicalpt_BR
Appears in Collections:Informe INCA 427

Files in This Item:
File Description SizeFormat 
Informe-INCA-2023-427-7-INCA-é-pioneiro.pdf318.58 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.